Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Lots of nonsense has been written on this board today on the way up and the way back down. Nothing has changed. That is what the RNS says.
To reiterate what Piper posted
“ Hello
Thank you for your message.
Our current capacity for lateral flow tests at Alva is 100,000 tests per week. We are currently in the process of increasing that to 200,000 tests per week and looking at options to further increase to 500,000 tests per week.
Our capacity in Littleport is currently just under 50,000 tests per day. We are currently looking to increase that to 100,000 per day.
That's up to 26m a year in Alva and 36.5 in Littleport. The consortium is working together to produce the POC test and then each manufacturer within the consortium will be able to commercialise it as much as they want.
The priority will be government orders however there will still be a huge international market so 50m test a year is achievable!
Ha ha muppets who have done no research at all. The company have just expanded capacity at Alva and advertised for 20 new lab techs.
The company will increase production at Littleport also near term and move up to producing over 4 million tests per mont which will be approaching the 50 mill per year which the CEO has obviously told the Sky News host and had to back peddle on.
This will fly up well over there when all this is confirmed.
Here’s the current capacity and near term expansion plans. Just add it up....
“ Hello
Thank you for your message.
Our current capacity for lateral flow tests at Alva is 100,000 tests per week. We are currently in the process of increasing that to 200,000 tests per week and looking at options to further increase to 500,000 tests per week.
Our capacity in Littleport is currently just under 50,000 tests per day. We are currently looking to increase that to 100,000 per day.
We only have two manufacturing sites.
Best wishes
Omega Diagnostics“
Investor 6.. you’re part of the clueless brigade.. cheerio
nonesense. complete rampers.
Where is your evidence? RAMP, RAMP, RAMP.
The price went up today because of rampers and the nonesense that Omega would do 50m tests. The truth is the consortium with 5 or 6 others will. Not Omega alone. Hence ODX said the following
"In a Sky News interview earlier today, the introduction referred to the Consortium being able to make 50m tests a year, a figure also referred to in a newspaper article published on 26 April 2020. This is not a figure that relates to the potential output from Omega and its manufacturing facilities alone."
w&nkers
This will fly on the main RNS. £1 - £2 coming